Latest stories on VNDA
Vanda Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 5, 2026
PR Newswire50 · neutralgeneral
Vanda Pharmaceuticals: Risks Rising, Rewards Dwindling - Why I'm Downgrading To Hold
Seeking Alpha38 · neutralanalyst
Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle & Vision Summit
PR Newswire55 · neutralgeneral
VNDA Stock Gains After-Hours As FDA Grants Rare Pediatric Disease Designation For Experimental Therapy
Stocktwits News63 · neutralproduct/pr
Here’s Why H.C. Wainwright Remains a Buy on Vanda Pharmaceuticals (VNDA)
Yahoo Top61 · neutralanalyst
Vanda Pharmaceuticals Inc. (VNDA) files 8-K
SEC 8-K50 · neutralgeneral
Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan for Imsidolimab in Generalized Pustular Psoriasis
PR Newswire63 · neutralproduct/pr
VNDA: [Form 4] Vanda Pharmaceuticals Inc. Insider Trading Activity
StockTitan SEC50 · neutralgeneral
Vanda Pharmaceuticals Announces Participation at May 2026 Investor Conferences
PR Newswire55 · neutralgeneral
Vanda Pharmaceuticals Q1 Earnings Call Highlights
Yahoo Top56 · neutralearnings
Vanda Pharmaceuticals Inc. Q1 2026 Earnings Call Summary
Yahoo Finance50 · neutralearnings
Vanda (VNDA) Q1 2026 Earnings Call Transcript
Yahoo Top50 · neutralearnings
Vanda Pharmaceuticals Reports First Quarter 2026 Financial Results
PR Newswire63 · neutralearnings